Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management.

ABSTRACT: Idiopathic intracranial hypertension (IIH) is a rare but important disease associated with significant morbidity. There is an expected rise in prevalence in line with the escalating global burden of obesity. Modern revisions in the terminology and diagnostic criteria for IIH help guide clinicians in investigations and researchers in standardising recruitment criteria for clinical trials. The pathophysiology of IIH is incompletely characterised; suggested underpinning mechanisms include the role of cerebrospinal fluid regulation as well as metabolic and endocrinological perspectives. Recent treatment trials are providing insights into the management but debate still surrounds key areas in treatment. This review will provide an up-to-date discussion on the potential pathogenic mechanisms and

SUBMITTER: Mollan SP 

PROVIDER: S-EPMC5013119 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature